These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 22052588)

  • 1. [Shock therapy: Which catecholamine is the best?].
    Werdan K
    Dtsch Med Wochenschr; 2011 Nov; 136(45):2292. PubMed ID: 22052588
    [No Abstract]   [Full Text] [Related]  

  • 2. [Arginine vasopressin in vasodilatory shock: a new therapy approach?].
    Dünser M; Wenzel V; Mayr AJ; Hasibeder WR
    Anaesthesist; 2002 Aug; 51(8):650-9; discussion 659-60. PubMed ID: 12391525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of Vasopressin Plus Catecholamine Vasopressors vs Catecholamines Alone With Atrial Fibrillation in Patients With Distributive Shock: A Systematic Review and Meta-analysis.
    McIntyre WF; Um KJ; Alhazzani W; Lengyel AP; Hajjar L; Gordon AC; Lamontagne F; Healey JS; Whitlock RP; Belley-Côté EP
    JAMA; 2018 May; 319(18):1889-1900. PubMed ID: 29801010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vasopressin in catecholamine-refractory shock in children.
    Meyer S; Gortner L; McGuire W; Baghai A; Gottschling S
    Anaesthesia; 2008 Mar; 63(3):228-34. PubMed ID: 18081903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does the Addition of Vasopressin to Catecholamine Vasopressors Affect Outcomes in Patients With Distributive Shock?
    Roumpf SK; Hunter BR
    Ann Emerg Med; 2019 Jul; 74(1):153-155. PubMed ID: 30446352
    [No Abstract]   [Full Text] [Related]  

  • 6. Vasopressin in sepsis and septic shock.
    Kampmeier TG; Rehberg S; Westphal M; Lange M
    Minerva Anestesiol; 2010 Oct; 76(10):844-50. PubMed ID: 20935620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characteristics of patients receiving vasopressors.
    Benbenishty J; Weissman C; Sprung CL; Brodsky-Israeli M; Weiss Y
    Heart Lung; 2011; 40(3):247-52. PubMed ID: 20630594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of terlipressin in a 14-year-old adolescent with catecholamine-resistant shock after severe traumatic brain injury.
    Meyer S; Gottschling S; Gortner L
    Acta Anaesthesiol Scand; 2007 Aug; 51(7):957. PubMed ID: 17635407
    [No Abstract]   [Full Text] [Related]  

  • 9. Review of vasopressor therapy in the setting of vasodilatory shock.
    Bockenstedt TL; Baker SN; Weant KA; Mason MA
    Adv Emerg Nurs J; 2012; 34(1):16-23. PubMed ID: 22313897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does dopamine administration in shock influence outcome? Results of the Sepsis Occurrence in Acutely Ill Patients (SOAP) Study.
    Sakr Y; Reinhart K; Vincent JL; Sprung CL; Moreno R; Ranieri VM; De Backer D; Payen D
    Crit Care Med; 2006 Mar; 34(3):589-97. PubMed ID: 16505643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renin and Survival in Patients Given Angiotensin II for Catecholamine-Resistant Vasodilatory Shock. A Clinical Trial.
    Bellomo R; Forni LG; Busse LW; McCurdy MT; Ham KR; Boldt DW; Hästbacka J; Khanna AK; Albertson TE; Tumlin J; Storey K; Handisides D; Tidmarsh GF; Chawla LS; Ostermann M
    Am J Respir Crit Care Med; 2020 Nov; 202(9):1253-1261. PubMed ID: 32609011
    [No Abstract]   [Full Text] [Related]  

  • 12. Arginine vasopressin in vasodilatory shock.
    Fuchs FD; Filho JW
    Circulation; 2003 Nov; 108(19):e141; author reply e141. PubMed ID: 14610004
    [No Abstract]   [Full Text] [Related]  

  • 13. [Catecholamines: pro and contra].
    Riessen R; Tschritter O; Janssens U; Haap M
    Med Klin Intensivmed Notfmed; 2016 Feb; 111(1):37-46. PubMed ID: 25804726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of exogenous arginine vasopressin in the management of catecholamine-refractory septic shock.
    Lee CS
    Crit Care Nurse; 2006 Dec; 26(6):17-23. PubMed ID: 17123948
    [No Abstract]   [Full Text] [Related]  

  • 15. Vasoactive drugs for vasodilatory shock in ICU.
    Holmes CL; Walley KR
    Curr Opin Crit Care; 2009 Oct; 15(5):398-402. PubMed ID: 19542884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Catecholamines for shock: the quest for high-quality evidence.
    Myburgh JA
    Crit Care Resusc; 2007 Dec; 9(4):352-6. PubMed ID: 18052900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Continuous terlipressin infusion as rescue treatment in a case series of children with refractory septic shock.
    Rodríguez-Núñez A; Oulego-Erroz I; Gil-Antón J; Pérez-Caballero C; López-Herce J; Gaboli M; Milano G;
    Ann Pharmacother; 2010 Oct; 44(10):1545-53. PubMed ID: 20841511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacologic support of the failing circulation: practice, education, evidence, and future directions.
    Bracco D
    Crit Care Med; 2006 Mar; 34(3):890-2. PubMed ID: 16505669
    [No Abstract]   [Full Text] [Related]  

  • 19. Vasoactive drugs in circulatory shock.
    Hollenberg SM
    Am J Respir Crit Care Med; 2011 Apr; 183(7):847-55. PubMed ID: 21097695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The response to methylene blue in patients with severe hypotension during liver transplantation.
    Cheng SS; Berman GW; Merritt GR; Hendrickse A; Fiegel MJ; Teitelbaum I; Campsen J; Wachs M; Zimmerman M; Mandell MS
    J Clin Anesth; 2012 Jun; 24(4):324-8. PubMed ID: 22608589
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.